Manguinhas, R.; Fernandes, A.S.; Costa, J.G.; Saraiva, N.; Camões, S.P.; Gil, N.; Rosell, R.; Castro, M.; Miranda, J.P.; Oliveira, N.G.
Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion. Antioxidants 2020, 9, 550.
https://doi.org/10.3390/antiox9060550
AMA Style
Manguinhas R, Fernandes AS, Costa JG, Saraiva N, Camões SP, Gil N, Rosell R, Castro M, Miranda JP, Oliveira NG.
Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion. Antioxidants. 2020; 9(6):550.
https://doi.org/10.3390/antiox9060550
Chicago/Turabian Style
Manguinhas, Rita, Ana S. Fernandes, João G. Costa, Nuno Saraiva, Sérgio P. Camões, Nuno Gil, Rafael Rosell, Matilde Castro, Joana P. Miranda, and Nuno G. Oliveira.
2020. "Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion" Antioxidants 9, no. 6: 550.
https://doi.org/10.3390/antiox9060550
APA Style
Manguinhas, R., Fernandes, A. S., Costa, J. G., Saraiva, N., Camões, S. P., Gil, N., Rosell, R., Castro, M., Miranda, J. P., & Oliveira, N. G.
(2020). Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion. Antioxidants, 9(6), 550.
https://doi.org/10.3390/antiox9060550